While most of the heavyweights have already reported their quarterly earnings, there are still plenty of names left on the docket. And as always, earnings reports can be a powerful catalyst.
Today's trade is in a $39B leading provider of software solutions for the global life sciences sector that is on the verge of breaking multi-year highs with an eye towards making a run at all-time highs.
Like the rest of the All Star Charts team, I spent last week in New Orleans. It was hot. It was muggy. But the food—oh man, the food—made it all worth it.
I think I hit all the cornerstones of New Orleans cuisine:
I talk all the time about how the options market makers are not stupid. Options are priced the way they are, when they are, because options market makers know what they are doing. Usually.
But once in a blue moon, they can get caught sleeping....
We love our bottoms-up scans here at All Star Charts. We tend to get really creative when making new universes as we want to be sure they will deliver us the best opportunities the market has to...
Going to keep this post short today. I'm writing live from the Portfolio Accelerator event in New Orleans. Our friend Riley Rosebee is presenting as I'm typing and he is talking about stocks in companies The Jetson's would invest in.